Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections

Glossary

What is Mild cognitive impairment?

Mild cognitive impairment, often shortened to MCI. A noticeable decline in memory or thinking that is more than normal aging but does not seriously interfere with daily life. Some people with it go on to develop dementia, and some do not.

Glossary entry, last updated October 11, 2026 · How we write the glossary

Related terms

Dementia
An umbrella term for a decline in memory and thinking severe enough to interfere with daily life. Alzheimer’s disease is the most common cause.
Montreal Cognitive AssessmentMoCA
A 30-point screening test of memory, attention, language and reasoning, widely used to detect mild cognitive impairment. Higher scores indicate better performance.
Cognitive decline
A fall in memory, attention or reasoning skills. Some decline is a normal part of aging, and a faster or larger decline can signal a condition such as dementia.

Research that mentions mild cognitive impairment

19 studies in our archive have this term in the title. The newest are below.

Brain & Neurology

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial

Cognitive, metabolic, and network-level findings are consistent with enhanced mitochondrial efficiency and anti-inflammatory effects. These results support larger, double-blind, multicenter trials to evaluate tPBM as a mitochondria-targeted therapy in early ADRD.

Trial · June 3, 2026 · Rashidi-Ranjbar N et al.

Brain & Neurology

The Impact of Transcranial Direct Stimulation Therapy Combined with Intranasal Near-Infrared Stimulation on Cognitive Performance in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Study

Combined tDCS and iNIRS therapy significantly enhances cognitive performance in patients with MCI and mild AD. This synergistic, non-invasive approach may offer a promising therapeutic strategy to delay cognitive decline and reduce care-related burdens.

Study · April 17, 2026 · Woźniak-Mitał J et al.

Search all studies for Mild cognitive impairment

Read this with care

  • This entry is general information, not medical advice. See the disclaimer.
  • Definitions are written for readers new to the field and may be simplified. Check the full paper when it matters.
  • Found a mistake? Tell us.